Appendix B: Sources of evidence considered by the Committee

Appendix B: Sources of evidence considered by the Committee

A. The assessment report for this appraisal was prepared by NHS Centre for Reviews and Dissemination/Centre for Health Economics, University of York:

  • McDaid C, Griffin S, Weatherly H, et al. The continuous positive airway pressure for the treatment of obstructive sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis, June 2007.

B. The following organisations accepted the invitation to participate in this appraisal. They were invited to make submissions and comment on the draft scope, assessment report and the appraisal consultation document (ACD). Organisations listed in I and II were also invited to make written submissions and have the opportunity to appeal against the final appraisal determination.

I) Manufacturers/sponsors:

  • Fisher & Paykel Healthcare (SleepStyle 230 and 600 series)

  • Respironics UK (REMstar series)

  • ResMed (UK) (S8 series)

  • Sunrise Medical – DeVilbiss (RPM BiLevel 9055, RPM 9054, AutoAdjust and Horizon range)

  • Tyco Healthcare (GoodKnight 420 series)

  • Vital Signs (Breas range)

II) Professional/specialist and patient/carer groups:

  • Association for Respiratory Technology and Physiology

  • British Sleep Society

  • British Society of Dental Sleep Medicine

  • British Thoracic Society

  • Cochrane Airways Group

  • General Practice Airways Group

  • Royal College of Anaesthetists

  • Royal College of General Practitioners

  • Royal College of Nursing

  • Royal College of Physicians

  • Royal College of Physicians of Edinburgh

  • Royal College of Surgeons

  • Royal Society of Medicine – Sleep Medicine Section

  • Sleep Apnoea Trust

  • Welsh Assembly Government

III) Commentator organisations (without the right of appeal):

  • Department of Health, Social Services and Public Safety for Northern Ireland

  • NHS Quality Improvement Scotland

C. The following individuals were selected from clinical specialist and patient advocate nominations from the non-manufacturer/sponsor consultees and commentators. They participated in the Appraisal Committee discussions and provided evidence to inform the Appraisal Committee's deliberations. They gave their expert personal view on continuous positive airway pressure for the treatment of obstructive sleep apnoea/hypopnoea syndrome by attending the initial Committee discussion and/or providing written evidence to the Committee. They were also invited to comment on the ACD.

  • Professor John Gibson, Professor of Respiratory Medicine, nominated by British Thoracic Society – clinical specialist

  • Professor John Stradling, Professor of Respiratory Medicine, nominated by the Sleep Apnoea Trust – clinical specialist

  • Mr Frank Govan, Chair of Trustees, Sleep Apnoea Trust, nominated by the Sleep Apnoea Trust – patient expert

  • Mr Rob Holt, nominated by the Sleep Apnoea Trust – patient expert